Becton Dickinson Earns EUA for Point-of-Care COVID-19 Test

Becton Dickinson (BD) has received an Emergency Use Authorization from the FDA for its SARS-CoV-2 diagnostic test for use on its BD Veritor Plus System.

The portable system is slightly larger than a cell phone and is used in more than 25,000 hospitals, clinician offices, urgent care centers and pharmacies, BD said.

The assay delivers results within 15 minutes and does not require laboratory personnel. The company plans to manufacture up to 10 million tests from July through September.